Brief: Pharming Group FY Net Loss At $11 Million
13/03/2025 06:07
March 13 (Reuters) - Pharming Group NV PHAR.AS: FY NET INCOME USD -11 MILLION FY GROSS PROFIT USD 261.8 MILLION FY OPERATING PROFIT USD -8.6 MILLION FY BASIC EPS USD -0.016 FY EPS USD -0.016 FULL YEAR 2024 TOTAL REVENUES INCREASED BY 21% TO US$297.2 MILLION 2025 TOTAL REVENUE GUIDANCE OF US$315 MILLION - US$335 MILLION FABRICE CHOURAQUI APPOINTED AS CEO AND EXECUTIVE DIRECTOR Source text: ID:nGNE7pDdcH Further company coverage: PHAR.AS (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))